138 related articles for article (PubMed ID: 32229658)
1. Diverse fragment lengths dismiss size selection for serum cell-free DNA: a comparative study of serum and plasma samples.
Huang Y; Mu J; Qi L; Ge W; Fang X; Song Y; Yuan Y; Zheng S
Clin Chem Lab Med; 2020 Aug; 58(9):1451-1459. PubMed ID: 32229658
[TBL] [Abstract][Full Text] [Related]
2. Enhanced detection of circulating tumor DNA by fragment size analysis.
Mouliere F; Chandrananda D; Piskorz AM; Moore EK; Morris J; Ahlborn LB; Mair R; Goranova T; Marass F; Heider K; Wan JCM; Supernat A; Hudecova I; Gounaris I; Ros S; Jimenez-Linan M; Garcia-Corbacho J; Patel K; Østrup O; Murphy S; Eldridge MD; Gale D; Stewart GD; Burge J; Cooper WN; van der Heijden MS; Massie CE; Watts C; Corrie P; Pacey S; Brindle KM; Baird RD; Mau-Sørensen M; Parkinson CA; Smith CG; Brenton JD; Rosenfeld N
Sci Transl Med; 2018 Nov; 10(466):. PubMed ID: 30404863
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and Prognostic Value of Circulating DNA Fragments in Glioblastoma Multiforme Patients.
Jarmuzek P; Wawrzyniak-Gramacka E; Morawin B; Tylutka A; Zembron-Lacny A
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673808
[TBL] [Abstract][Full Text] [Related]
4. Plasma vs. serum in circulating tumor DNA measurement: characterization by DNA fragment sizing and digital droplet polymerase chain reaction.
Lee JS; Kim M; Seong MW; Kim HS; Lee YK; Kang HJ
Clin Chem Lab Med; 2020 Mar; 58(4):527-532. PubMed ID: 31874093
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinoma.
Yamamoto Y; Uemura M; Fujita M; Maejima K; Koh Y; Matsushita M; Nakano K; Hayashi Y; Wang C; Ishizuya Y; Kinouchi T; Hayashi T; Matsuzaki K; Jingushi K; Kato T; Kawashima A; Ujike T; Nagahara A; Fujita K; Imamura R; Nakagawa H; Nonomura N
Cancer Sci; 2019 Feb; 110(2):617-628. PubMed ID: 30536551
[TBL] [Abstract][Full Text] [Related]
6. Quantitative characterization of tumor cell-free DNA shortening.
Guo J; Ma K; Bao H; Ma X; Xu Y; Wu X; Shao YW; Jiang M; Huang J
BMC Genomics; 2020 Jul; 21(1):473. PubMed ID: 32650715
[TBL] [Abstract][Full Text] [Related]
7. Origin of circulating free DNA in patients with lung cancer.
Abe T; Nakashima C; Sato A; Harada Y; Sueoka E; Kimura S; Kawaguchi A; Sueoka-Aragane N
PLoS One; 2020; 15(7):e0235611. PubMed ID: 32634139
[TBL] [Abstract][Full Text] [Related]
8. Quantification of circulating plasma cell free DNA fragments in patients with oral cancer and precancer.
Desai A; Kallianpur S; Mani A; Tijare MS; Khan S; Jain M; Mathur V; Ahuja R; Saxena V
Gulf J Oncolog; 2018 May; 1(27):11-17. PubMed ID: 30145546
[TBL] [Abstract][Full Text] [Related]
9. Refined characterization of circulating tumor DNA through biological feature integration.
Markus H; Chandrananda D; Moore E; Mouliere F; Morris J; Brenton JD; Smith CG; Rosenfeld N
Sci Rep; 2022 Feb; 12(1):1928. PubMed ID: 35121756
[TBL] [Abstract][Full Text] [Related]
10. The clinical value of circulating free tumor DNA in testicular germ cell tumor patients.
Boublikova L; Kramarzova KS; Zwyrtkova M; Bakardjieva-Mihaylova V; Stuchly J; Rosova B; Kolostova K; Sonsky J; Kindlova E; Zachoval R; Buchler T; Trka J
Urol Oncol; 2022 Sep; 40(9):412.e15-412.e24. PubMed ID: 35729018
[TBL] [Abstract][Full Text] [Related]
11. Optimization of Preanalytical Variables for cfDNA Processing and Detection of ctDNA in Archival Plasma Samples.
Nesic M; Bødker JS; Terp SK; Dybkær K
Biomed Res Int; 2021; 2021():5585148. PubMed ID: 34307658
[TBL] [Abstract][Full Text] [Related]
12. Chimeric External Control to Quantify Cell Free DNA in Plasma Samples by Real Time PCR.
Eini M; Behzad-Behbahani A; Takhshid MA; Ramezani A; Rafiei Dehbidi GR; Okhovat MA; Farhadi A; Alavi P
Avicenna J Med Biotechnol; 2016; 8(2):84-90. PubMed ID: 27141267
[TBL] [Abstract][Full Text] [Related]
13. Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis.
Ponti G; Maccaferri M; Manfredini M; Micali S; Torricelli F; Milandri R; Del Prete C; Ciarrocchi A; Ruini C; Benassi L; Bettelli S; Kaleci S; Ozben T; Tomasi A
Clin Chim Acta; 2019 Oct; 497():76-80. PubMed ID: 31301282
[TBL] [Abstract][Full Text] [Related]
14. Analysis of recurrently protected genomic regions in cell-free DNA found in urine.
Markus H; Zhao J; Contente-Cuomo T; Stephens MD; Raupach E; Odenheimer-Bergman A; Connor S; McDonald BR; Moore B; Hutchins E; McGilvrey M; de la Maza MC; Van Keuren-Jensen K; Pirrotte P; Goel A; Becerra C; Von Hoff DD; Celinski SA; Hingorani P; Murtaza M
Sci Transl Med; 2021 Feb; 13(581):. PubMed ID: 33597261
[TBL] [Abstract][Full Text] [Related]
15. Liquid biopsy with cell free DNA: new horizons for prostate cancer.
Ponti G; Maccaferri M; Percesepe A; Tomasi A; Ozben T
Crit Rev Clin Lab Sci; 2021 Jan; 58(1):60-76. PubMed ID: 32805148
[TBL] [Abstract][Full Text] [Related]
16. Direct quantification of cell-free, circulating DNA from unpurified plasma.
Breitbach S; Tug S; Helmig S; Zahn D; Kubiak T; Michal M; Gori T; Ehlert T; Beiter T; Simon P
PLoS One; 2014; 9(3):e87838. PubMed ID: 24595313
[TBL] [Abstract][Full Text] [Related]
17. The effect of surgical trauma on circulating free DNA levels in cancer patients-implications for studies of circulating tumor DNA.
Henriksen TV; Reinert T; Christensen E; Sethi H; Birkenkamp-Demtröder K; Gögenur M; Gögenur I; Zimmermann BG; ; Dyrskjøt L; Andersen CL
Mol Oncol; 2020 Aug; 14(8):1670-1679. PubMed ID: 32471011
[TBL] [Abstract][Full Text] [Related]
18. Increased level and fragmentation of plasma circulating cell-free DNA are diagnostic and prognostic markers for renal cell carcinoma.
Yamamoto Y; Uemura M; Nakano K; Hayashi Y; Wang C; Ishizuya Y; Kinouchi T; Hayashi T; Matsuzaki K; Jingushi K; Kato T; Kawashima A; Ujike T; Nagahara A; Fujita K; Imamura R; Nonomura N
Oncotarget; 2018 Apr; 9(29):20467-20475. PubMed ID: 29755665
[TBL] [Abstract][Full Text] [Related]
19. Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer.
Werner B; Yuwono N; Duggan J; Liu D; David C; Srirangan S; Provan P; ; DeFazio A; Arora V; Farrell R; Lee YC; Warton K; Ford C
Gynecol Oncol; 2021 Sep; 162(3):720-727. PubMed ID: 34454680
[TBL] [Abstract][Full Text] [Related]
20. Comparison of serum cell-free DNA between postmortem and living samples.
Fujihara J; Takinami Y; Kawai Y; Kimura-Kataoka K; Takeshita H
Clin Chim Acta; 2021 Aug; 519():255-259. PubMed ID: 34015305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
